1. Home
  2. Research and Funding
  3. Current Funding Opportunities
  4. Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01)

Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01)

The overarching goal of this Funding Opportunity Announcement (FOA) is to translate basic science research into knowledge and tools that can be utilized to provide strong justification for later-phase therapeutics discovery and development efforts in health-related outcomes relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes outcomes relevant to obesity, diabetes and related aspects of endocrinology and metabolism, digestive diseases, liver diseases, nutrition, kidney and urological diseases, hematology, and specific aspects of cystic fibrosis. Additional information concerning programmatic areas at NIDDK is available at: www.niddk.nih.gov/research-funding/research-programs/Pages/default.aspx.

Funding Opportunity Details

PAR-16-121
NOT-DK-18-002; NOT-OD-18-009; NOT-OD-17-114; NOT-OD-17-062; NOT-OD-16-004

Aaron C. Pawlyk, Ph.D.

Key Dates

5/5/2016

February 12, 2018, June 12, 2018, October 12, 2018, and February 12, 2019

New Dates March 12, 2018, July 12, 2018, November 12, 2018, and March 12, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.